Bugworks raised $7.5 million in a fresh funding round
Nabanita Dutta
News Editor
Image Credit: shortpedia
Bugworks research, the biopharma startup has recently raised $7.5 million in a funding round that was led by the University of Tokyo Edge Capital Global Brain Corporation and South Africa based Acquipharma Holdings. The Bugworks officials have said that the new funding will help them in their mission of pandemic preparedness by defeating superbug infections. The announcement came amid the COVID-19 crisis.
